JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

Search

Phreesia Inc

Gesloten

SectorGezondheidszorg

27.09 0.11

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

26.8

Max

28.27

Belangrijke statistieken

By Trading Economics

Inkomsten

2.5M

-3.9M

Verkoop

6.3M

116M

Winstmarge

-3.376

Werknemers

2,082

EBITDA

2M

4.1M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+17.3% upside

Dividenden

By Dow Jones

Volgende Winsten

3 sep 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

193M

1.6B

Vorige openingsprijs

26.98

Vorige sluitingsprijs

27.09

Nieuwssentiment

By Acuity

29%

71%

76 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

Phreesia Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 aug 2025, 22:24 UTC

Winsten
Belangrijke Marktbewegers

Airbnb Logs 2Q Beat, But Investments Weigh on Margin Outlook -- Update

6 aug 2025, 23:43 UTC

Marktinformatie

Nikkei May Decline Amid Uncertainty Over Earnings, U.S. Tariffs -- Market Talk

6 aug 2025, 23:39 UTC

Marktinformatie

Gold Steady as Traders Assess Geopolitical, Tariff Developments -- Market Talk

6 aug 2025, 23:28 UTC

Winsten

Kakao 2Q Net Profit Beat FactSet-Compiled Consensus

6 aug 2025, 23:28 UTC

Winsten

Kakao 2Q Net KRW171.82B Vs. Net KRW87.15B >035720.SE

6 aug 2025, 23:28 UTC

Winsten

Kakao 2Q Oper Pft KRW185.93B Vs. Pft KRW133.96B >035720.SE

6 aug 2025, 23:28 UTC

Winsten

Kakao 2Q Rev KRW2.028T Vs. KRW2.005T >035720.SE

6 aug 2025, 23:14 UTC

Winsten

Fiserv, Shift4, Toast Stocks Tumble on Earnings. Analysts Are Optimistic Anyway. -- Barrons.com

6 aug 2025, 23:01 UTC

Winsten

United Overseas Bank 2Q Net Interest Income S$2.34B Vs. S$2.40B >U11.SG

6 aug 2025, 23:01 UTC

Winsten

United Overseas Bank 2Q Total Income S$3.47B Vs. S$3.48B >U11.SG

6 aug 2025, 23:00 UTC

Winsten

United Overseas Bank 2Q Net S$1.34B Vs. Net S$1.43B >U11.SG

6 aug 2025, 22:54 UTC

Marktinformatie

New Zealand Companies Should Avoid Qualifying Profit Improvement -- Market Talk

6 aug 2025, 22:41 UTC

Winsten

DBS 2Q Allowances for Credit, Other Losses S$133.0M Vs. S$148.0M >D05.SG

6 aug 2025, 22:38 UTC

Winsten

DBS 2Q Net Interest Income S$3.63B Vs. S$3.77B >D05.SG

6 aug 2025, 22:38 UTC

Winsten

DBS 2Q Total Income S$5.73B Vs. S$5.48B >D05.SG

6 aug 2025, 22:38 UTC

Winsten

DBS 2Q Net S$2.82B Vs. Net S$2.80B >D05.SG

6 aug 2025, 22:28 UTC

Marktinformatie

NZX Bear Says Growth Likely to Miss Market's Hopes -- Market Talk

6 aug 2025, 22:11 UTC

Winsten

Pan American Silver 2Q Rev $811.90 >PAAS

6 aug 2025, 22:11 UTC

Winsten

Pan American Silver Raises Dividend to 12c >PAAS

6 aug 2025, 22:11 UTC

Winsten

Pan American Silver 2Q EPS 52c >PAAS

6 aug 2025, 22:03 UTC

Winsten

Nutrien 2Q Sales $10.44B >NTR.T

6 aug 2025, 22:03 UTC

Winsten

Nutrien: Nitrogen Sales Volume Guidance of 10.7MMT to 11.2MMT Assumes Lower Ammonia Operating Rates in 2H Compared to Record Achieved in 1H Due to Planned Turnaround Activity a North Amer Plants >NTR.T

6 aug 2025, 22:03 UTC

Winsten

Nutrien: Phosphate Sales Volume Guidance of 2.35MMT to 2.55MMT Assumes Improved Operating Rates, Sales Volumes in 2H Compared to Prior Yr With Completion of Planned Turnarounds in 1H >NTR.T

6 aug 2025, 22:03 UTC

Winsten

Nutrien: Potash Sales Volume Guidance Was Increased to 13.9MMT to 14.5MMT Due to Expectations for Higher Global Demand in 2025 >NTR.T

6 aug 2025, 22:03 UTC

Winsten

Nutrien 2Q EPS $2.50 >NTR.T

6 aug 2025, 22:03 UTC

Acquisities, Fusies, Overnames

A Family Feud Leaves the Future of This Kefir -2-

6 aug 2025, 22:03 UTC

Acquisities, Fusies, Overnames

A Family Feud Leaves the Future of This Kefir King in Doubt. Danone May Take Over. -- Barrons.com

6 aug 2025, 22:00 UTC

Marktinformatie
Winsten

Airbnb 2Q Results Overshadowed by EBITDA Outlook -- Market Talk

6 aug 2025, 21:53 UTC

Acquisities, Fusies, Overnames

Parataxis Holdings: Combines Bitcoin Exposure, Proprietary Growth Opportunities, Accretive Yield Generation >SBXD

6 aug 2025, 21:53 UTC

Acquisities, Fusies, Overnames

Parataxis Holdings: Once Proposed Transaction Is Closed, Combined Co Will Be Named Parataxis Holdings Inc. and Seek to Trade on NYSE Under the Symbol 'PRTX' >SBXD

Peer Vergelijking

Prijswijziging

Phreesia Inc Prognose

Koersdoel

By TipRanks

17.3% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 32 USD  17.3%

Hoogste 34 USD

Laagste 29 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Phreesia Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

9 ratings

9

Buy

0

Hold

0

Sell

Technische score

By Trading Central

25.23 / 25.61Steun & Weerstand

Korte Termijn

Neutral Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Bullish Evidence

Sentiment

By Acuity

76 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.